Two Strategies for the Development of Mitochondrion-Targeted Small Molecule Radiation Damage Mitigators
Jean-Claude M. Rwigema,Barbara Beck,Wei Wang,Alexander Doemling,Michael W. Epperly,Donna Shields,Julie P. Goff,Darcy Franicola,Tracy Dixon,Marie-Céline Frantz,Peter Wipf,Yulia Tyurina,Valerian E. Kagan,Hong Wang,Joel S. Greenberger
DOI: https://doi.org/10.1016/j.ijrobp.2011.01.059
IF: 8.013
2011-01-01
International Journal of Radiation Oncology*Biology*Physics
Abstract:PURPOSE:To evaluate the effectiveness of mitigation of acute ionizing radiation damage by mitochondrion-targeted small molecules.
METHODS AND MATERIALS:We evaluated the ability of nitroxide-linked alkene peptide isostere JP4-039, the nitric oxide synthase inhibitor-linked alkene peptide esostere MCF201-89, and the p53/mdm2/mdm4 protein complex inhibitor BEB55 to mitigate radiation effects by clonogenic survival curves with the murine hematopoietic progenitor cell line 32D cl 3 and the human bone marrow stromal (KM101) and pulmonary epithelial (IB3) cell lines. The p53-dependent mechanism of action was tested with p53(+/+) and p53(-/-) murine bone marrow stromal cell lines. C57BL/6 NHsd female mice were injected i.p. with JP4-039, MCF201-89, or BEB55 individually or in combination, after receiving 9.5 Gy total body irradiation (TBI).
RESULTS:Each drug, JP4-039, MCF201-89, or BEB55, individually or as a mixture of all three compounds increased the survival of 32D cl 3 (p = 0.0021, p = 0.0011, p = 0.0038, and p = 0.0073, respectively) and IB3 cells (p = 0.0193, p = 0.0452, p = 0.0017, and p = 0.0019, respectively) significantly relative to that of control irradiated cells. KM101 cells were protected by individual drugs (p = 0.0007, p = 0.0235, p = 0.0044, respectively). JP4-039 and MCF201-89 increased irradiation survival of both p53(+/+) (p = 0.0396 and p = 0.0071, respectively) and p53(-/-) cells (p = 0.0007 and p = 0.0188, respectively), while BEB55 was ineffective with p53(-/-) cells. Drugs administered individually or as a mixtures of all three after TBI significantly increased mouse survival (p = 0.0234, 0.0009, 0.0052, and 0.0167, respectively).
CONCLUSION:Mitochondrial targeting of small molecule radiation mitigators decreases irradiation-induced cell death in vitro and prolongs survival of lethally irradiated mice.